Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cefazolin measurement |
Component |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Cephazolin poisoning |
Causative agent |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Accidental cephazolin poisoning |
Causative agent |
False |
Cefazolin |
Inferred relationship |
Some |
|
Intentional cephazolin poisoning |
Causative agent |
False |
Cefazolin |
Inferred relationship |
Some |
|
forgiftning med cefazolin, uvist med hvilken hensigt |
Causative agent |
False |
Cefazolin |
Inferred relationship |
Some |
1 |
Cephazolin adverse reaction |
Causative agent |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Allergy to cefazolin (finding) |
Causative agent |
False |
Cefazolin |
Inferred relationship |
Some |
|
Cephazolin overdose |
Causative agent |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Accidental cephazolin overdose |
Causative agent |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Intentional cephazolin overdose |
Causative agent |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
overdosis af cephazolin, uvist med hvilken hensigt |
Causative agent |
False |
Cefazolin |
Inferred relationship |
Some |
1 |
Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefazolin |
Inferred relationship |
Some |
|
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefazolin |
Inferred relationship |
Some |
|
cefazolin 250 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefazolin |
Inferred relationship |
Some |
|
cefazolin 5 g pulver til injektionsvæske, rekonstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefazolin |
Inferred relationship |
Some |
|
cefazolin 10 g pulver til injektionsvæske, rekonstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefazolin |
Inferred relationship |
Some |
|
cefazolin 20 g pulver til injektionsvæske, rekonstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefazolin |
Inferred relationship |
Some |
|
cefazolin 500 mg infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefazolin |
Inferred relationship |
Some |
|
cefazolin 1 g infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefazolin |
Inferred relationship |
Some |
|
Cefazolin sodium |
Is a |
False |
Cefazolin |
Inferred relationship |
Some |
|
Product containing cefazolin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Accidental cephazolin poisoning |
Causative agent |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Intentional cephazolin poisoning |
Causative agent |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Cefazolin (as cefazolin sodium) 10 g powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefazolin |
Inferred relationship |
Some |
|
Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefazolin |
Inferred relationship |
Some |
|
Allergy to cefazolin (finding) |
Causative agent |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Product containing cefazolin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Cefazolin sodium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cefazolin |
Inferred relationship |
Some |
|
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Product containing only cefazolin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Cefazolin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Cefazolin (as cefazolin sodium) 10 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Cefazolin (as cefazolin sodium) 2 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Product containing precisely cefazolin (as cefazolin sodium) 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Product containing precisely cefazolin (as cefazolin sodium) 2 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefazolin |
Inferred relationship |
Some |
1 |
Cefazolin therapy |
Direct substance |
True |
Cefazolin |
Inferred relationship |
Some |
1 |